Market cap
$6.6M
52-week range44% up the range
$2.98$6.70

ENDRA Life Sciences Inc. (NDRA) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for NDRA, including 1 13D/G filing, 1 earnings update and 1 SEC filing. The most recent was published Nov 16, 2026.

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Price$4.63+0.21 (+4.63%)
2026-08-142026-11-16

Financial highlights

Full financials
Net income, TTM
-$5.85M
Cash
$1.52M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks21+50%
2026-05-24: 22026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 52026-06-28: 12026-07-05: 12026-07-12: 22026-07-19: 02026-07-26: 02026-08-02: 12026-08-09: 02026-08-16: 22026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 12026-09-20: 12026-09-27: 22026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 12026-11-15: 2
2026-05-242026-11-15
Mix790d
  • SEC Filings5(71%)
  • 13D/G1(14%)
  • Earnings1(14%)
Activity · 52 weeks4427 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

NDRA FAQ

9 questions
  • What does ENDRA Life Sciences Inc. do?
    ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about...
  • What is the latest news on NDRA?
    In the last 30 days Quantisnow tracked 3 wire items for NDRA: 1 13D/G filing, 1 earnings update and 1 SEC filing. The most recent was published on November 16, 2026.
  • Is NDRA profitable?
    No. ENDRA Life Sciences Inc. reported a net loss of $5.85M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does NDRA have?
    ENDRA Life Sciences Inc. reported $1.52M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does NDRA stock trade?
    ENDRA Life Sciences Inc. (NDRA) is listed on NASDAQ.
  • What sector and industry is NDRA in?
    ENDRA Life Sciences Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • When did ENDRA Life Sciences Inc. go public?
    ENDRA Life Sciences Inc. (NDRA) completed its IPO in 2017.
  • What companies are similar to NDRA?
    Notable peers in the same industry include IRTC (iRhythm Holdings Inc.), BFLY (Butterfly Network Inc.). Compare NDRA side-by-side with any of them on Quantisnow.
  • How can I track NDRA on Quantisnow?
    Quantisnow aggregates ENDRA Life Sciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NDRA to receive live email and push alerts on every new disclosure.